Workday, Inc. (NASDAQ:WDAY – Get Free Report) has been given a consensus rating of “Moderate Buy” by the twenty-seven brokerages that are covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, six have given a hold recommendation and twenty have issued a buy recommendation on the […]

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Get Free Report) has been given an average recommendation of “Moderate Buy” by the ten analysts that are currently covering the firm, Marketbeat reports. Three equities research analysts have rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average 12-month price […]